The effectiveness of the four-month regimen was proved on the basis of recurrence levels, number of patients testing negative in sputum sme...

Granted by the Mexican Institute of Industrial Property, the patent protects the composition of Potentox, the company said.

Venus Remedies has got US patent for Potentox, used for pneumonia other infections and is looking at increasing presence in the $ 12 bn ant...

Elder Pharmaceuticals has earmarked a Rs 40-crore investment for a rural thrust and set up a dedicated division called 'Elvista' to spread ...

Elder Pharmaceuticals is increasing its focus on the rural market.

Ranbaxy has emerged as the leader in the domestic pharmaceutical retail market, with a share of 5.2% for the April to June quarter. Insuran...

Anu's Laboratories plans to enter the capital market on May 12 with its initial public offering of 38,20,000 equity shares at a price to be...

Domestic pharma major Wockhardt has filed a case with the Bombay High Court, after the Indian Patent office rejected its patent application...

The case will reopen the debate on value of incremental innovation as cos seek clarity on patent law.

The patent office in Mumbai has rejected Wockhardt’s application for a product patent for its product - nadifloxacin - a topical antibiotic...

Wockhardt has signed an in-licensing agreement with LSI, a UK-based company specialising in dermatology, to market Vitix, a patented produc...